Elastic liposomes for skin delivery of dipotassium glycyrrhizinate

被引:170
作者
Trotta, M [1 ]
Peira, E [1 ]
Debernardi, F [1 ]
Gallarate, M [1 ]
机构
[1] Univ Turin, Dipartimento Sci & Tecnol Farmaco, I-10125 Turin, Italy
关键词
elastic liposomes; dipotassium glycyrrhizinate; skin delivery;
D O I
10.1016/S0378-5173(02)00266-1
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The aim of this study was to evaluate the possibility of using liposomes for skin delivery of dipotassium glycyrrhizinate (KG), an anti-inflammatory agent employed in treating acute and chronic dermatitis, and of formulating such liposomes in an oil-in-water emulsion (O/W). KG had emulsifying properties and the possibility of producing elastic liposomes was verified. Liposomes containing soya lecithin (PC) or hydrogenated soya lecithin (HPC) mixed kith KG in w/w ratios of 2:1. 4:1 or 8:1 were prepared by the solvent evaporation method and then passed through a high pressure homogeniser. Liposome size and entrapment efficiency were determined and the interaction between KG and HPC was investigated using differential scanning calorimetry (DSC). Transepidermal permeation through intact pig skin and skin deposition of KG from liposomes and 0 W emulsion containing liposomes were assessed and compared with values for aqueous control solutions. No marked differences were observed between PC and HPC liposomes. Liposome sizes ranged from 90 to 120 nm. Entrapment efficiency depended on the lipid:KG ration the maximum efficiency was obtained at 4:1 KG interacted with liposomes liposomes able to penetrate through membrane pores of disrupting and fluidising the lipid bilayer. forming elastic diameter much smaller than their own diameter. The liposome Structure was maintained when dispersed in an 0;:W emulsion. The skin fluxes were less than the HPLC detection limit for all systems, while skin deposition increased 4.5-fold compared with aqueous Solutions when KG was formulated in liposomes. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:319 / 327
页数:9
相关论文
共 19 条
[1]
ESTIMATION OF THE PORE-SIZE AND CHARGE-DENSITY IN HUMAN CADAVER SKIN [J].
AGUILELLA, V ;
KONTTURI, K ;
MURTOMAKI, L ;
RAMIREZ, P .
JOURNAL OF CONTROLLED RELEASE, 1994, 32 (03) :249-257
[2]
BARRY B W, 1987, Journal of Controlled Release, V6, P85, DOI 10.1016/0168-3659(87)90066-6
[3]
BARRY BW, 1983, DERMATOLIGAL FORMULA
[4]
The skin: A pathway for systemic treatment with patches and lipid-based agent carriers [J].
Cevc, G ;
Blume, G ;
Schatzlein, A ;
Gebauer, D ;
Paul, A .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 18 (03) :349-378
[5]
EGBARIA K, 1990, Advanced Drug Delivery Reviews, V5, P287, DOI 10.1016/0169-409X(90)90021-J
[6]
Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration [J].
El Maghraby, GMM ;
Williams, AC ;
Barry, BW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2000, 196 (01) :63-74
[7]
ELIAS PM, 1977, J CELL BIOL, V65, P577
[8]
PERCUTANEOUS ABSORPTION - RELEVANCE OF INVITRO DATA [J].
FRANZ, TJ .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1975, 64 (03) :190-195
[9]
HADGRAFT J, 1992, DRUG TARGETTING DELI, V12, P167
[10]
Kerube M., 1970, J KEIO MED SOC, V47, P331